Coronavirus disease 2019 (2019) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Over a year into the COVID-19 pandemic, new variants of concern
Coronavirus disease 2019 (2019) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Over a year into the COVID-19 pandemic, new variants of concern
Fox News Flash top headlines for March 23 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. Pfizer has begun a U.S.-based clinical trial
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to
A new COVID-19 antibody test superior to those currently available has been developed by researchers at the University of Aberdeen in collaboration with Vertebrate Antibodies Ltd and NHS
Researchers based in Beijing and Shenzhen, China, report that they have identified mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may allow
With the continuing spread of the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers have worked frantically to bring out
COVID-19, the source of the current pandemic, may be caused by a single virus, but it has a variety of presentations that make treatment difficult. Children, for example,
Researchers found that neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can increase over time. They observed that samples taken from convalescent plasma in September 2020
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NUCALA® mepolizumab 100 mg powder for injection Australian Consumer Medicine Information What is in this
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
